January 2019 interview with Dr Stan Hazen of Cleveland Clinic.
About Trimethylamine-Oxide (TMAO) ... and it's proposed role in Heart Disease.
The Hazen Lab published a paper in 2011 saying TMAO was a factor in CVD.
Since then they have been working on a TMA-blocker pill in conjunction with Procter & Gamble.
The over-the-counter pill will hopefully be on sale in 1-3 years.
0 comments: